This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa
The drug REBIF contains one active pharmaceutical ingredient (API):
1
Interferon beta-1a
UNII XRO4566Q4R - INTERFERON BETA-1A
|
Interferon beta-1a exerts its biological effects by binding to specific receptors on the surface of human cells. This binding initiates a complex cascade of intracellular events that leads to the expression of numerous interferon-induced gene products and markers. Whether the mechanism of action of interferon beta-1a in MS is mediated by the same pathway as the biological effects described above is not known because the pathophysiology of MS is not well established. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
L03AB07 | Interferon beta-1a | L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AB Interferons |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8403G, 8968B, 9332E |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 525420401153414, 525420402151415 |
Country: CA | Health Products and Food Branch | Identifier(s): 02237319, 02237320, 02318253, 02318261 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 26.640-10-05 |
Country: EE | Ravimiamet | Identifier(s): 1010866, 1035931, 1071638, 1071683, 1117639, 1117640, 1226607, 1430660, 1430671, 1489147, 1489158, 1489169, 1489305, 1489316, 1489327, 1489338, 1489349, 1646704, 1646715, 1778508, 1778519 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 98063008, 98063009, 98063009IP |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 032660, 034977, 034988, 036108, 059873, 151341, 156713, 169894, 518977 |
Country: FR | Base de données publique des médicaments | Identifier(s): 62090595, 62332372, 62657978, 63866728, 66975533, 68319944, 68975699, 69483042 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 113916, 114131, 114155, 166030, 166033, 166369, 186508, 186511, 186516, 186518, 186524, 44036, 44068 |
Country: HK | Department of Health Drug Office | Identifier(s): 57955, 57957, 59718, 59719, 62254, 62255 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 88291, 88292, 88367, 88368, 88369, 88556, 88834 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 6117, 6118 |
Country: IT | Agenzia del Farmaco | Identifier(s): 034091013, 034091025, 034091037, 034091049, 034091052, 034091064, 034091076, 034091088, 034091090, 034091102, 034091114, 034091126, 034091138, 034091140, 034091153, 034091165, 034091177, 034091203, 034091215 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004423, 1005538, 1006944, 1006945, 1015559, 1015560, 1030645, 1036693, 1064264, 1071810, 1084982, 1084983, 1091260, 1091261, 1091262, 1091263, 1091264, 1091265, 1091266, 1091267, 1091268 |
Country: NL | Z-Index G-Standaard | Identifier(s): 14229897 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 100021, 100056, 100064, 100072, 100080, 100196 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 20695, 20696, 8897, 8898 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100085051, 100101666, 100159217, 100402439, 100402445 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W65162001, W65162002, W65162003, W65163001, W65163002, W65164001, W65164002, W65164003, W65165001 |
Country: SG | Health Sciences Authority | Identifier(s): 13974P, 13975P, 14524P, 14525P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 22073031H, 22073032H, 22073033H, 22073034H, 6363054H, 6363055H |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699777950186, 8699777950209, 8699777950216, 8699777950353, 8699777950360, 8699777950377, 8699777950384 |
Country: US | FDA, National Drug Code | Identifier(s): 44087-0022, 44087-0044, 44087-3322, 44087-3344 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 34/34/0096, 35/34/0188, 45/34/1025, 45/34/1026 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.